Evidence map›Paper›PMID 38390801›Full record

ArticleJournal of the American Heart Association2024

Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients With Chronic Inflammatory Disease.

Stephanie Brunner, Olga Covtun, Federico Moccetti, Lucca Loretz, Matthias Bossard, Adrian Attinger-Toller, Florim Cuculi, Mathias Wolfrum, Reto Kurmann, Stefan Toggweiler

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Stephanie BrunnerHeart Center Lucerne, Cardiology Division, Luzerner Kantonsspital Lucerne Switzerland.ORCID 0000-0001-7510-7062
Olga CovtunHeart Center Lucerne, Cardiology Division, Luzerner Kantonsspital Lucerne Switzerland.
Federico MoccettiHeart Center Lucerne, Cardiology Division, Luzerner Kantonsspital Lucerne Switzerland.ORCID 0000-0002-5794-5676
Lucca LoretzHeart Center Lucerne, Cardiology Division, Luzerner Kantonsspital Lucerne Switzerland.
Matthias BossardHeart Center Lucerne, Cardiology Division, Luzerner Kantonsspital Lucerne Switzerland.ORCID 0000-0002-8290-661X
Adrian Attinger-TollerHeart Center Lucerne, Cardiology Division, Luzerner Kantonsspital Lucerne Switzerland.
Florim CuculiHeart Center Lucerne, Cardiology Division, Luzerner Kantonsspital Lucerne Switzerland.ORCID 0009-0000-3331-8128
Mathias WolfrumHeart Center Lucerne, Cardiology Division, Luzerner Kantonsspital Lucerne Switzerland.
Reto KurmannHeart Center Lucerne, Cardiology Division, Luzerner Kantonsspital Lucerne Switzerland.ORCID 0000-0002-6273-0880
Stefan ToggweilerHeart Center Lucerne, Cardiology Division, Luzerner Kantonsspital Lucerne Switzerland.ORCID 0000-0002-7860-0298
Luzerner Kantonsspital · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic inflammatory disease (CID) accelerates atherosclerosis and the development of aortic stenosis. Data on long-term outcomes after transcatheter aortic valve implantation (TAVI) in those patients are missing. The aim of this study was to investigate the clinical long-term outcomes of patients with and without autoimmune-related CID undergoing TAVI for the treatment of severe aortic stenosis. METHODS AND

resultsFrom a prospective registry, consecutive patients with TAVI were included. Baseline clinic and imaging data (echocardiographic and computed tomography) were analyzed. Long-term (up to 5 years) clinical and echocardiographic outcomes were studied. Of 1000 consecutive patients (mean age 81±6 years, 46% female), 107 (11%) had CID; the most frequent entities included polymyalgia rheumatica (31%) and rheumatoid arthritis (28%). Patients with CID were predominantly female (60% versus 44%,

conclusionsThis real-world analysis found that patients with CID undergoing TAVI were associated with a higher risk of postinterventional infectious complications and rehospitalization due to infection. However, valve durability and survival seem not to differ between patients with TAVI with versus without CID.

Indexed as

Aortic Valve StenosisAtrial FibrillationHeart Valve ProsthesisTranscatheter Aortic Valve ReplacementAgedAged, 80 and overAortic ValveChronic DiseaseFemaleHumansMaleRegistriesRisk FactorsTreatment Outcomechronic inflammatory diseaselong‐term outcomeTAVITAVR

Identifiers

PMID38390801
PMCPMC10944066
OpenAlexW4392110261

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.